GLOW50 (GHK-Cu + TB-500 + BPC-157)
Research Peptide | Lyophilized Powder | Batch Tested
For laboratory research use only. Not for human or animal consumption. Insulated shipping · Styrofoam box available.
Product Overview
GLOW50 is a three-component research blend containing 35 mg GHK-Cu, 10 mg TB-500 and 5 mg BPC-157 per vial, totaling 50 mg. Each box contains 10 vials. It has a different composition from BBG50, which contains 50 mg GHK-Cu, 10 mg TB-500 and 10 mg BPC-157 per vial.
No published certificates yet.
SKU y presentación
| SKU | Por vial | Viales por caja | Precio de la caja |
|---|---|---|---|
| GLOW50 | 50 mg | 10 | 119,00 US$ |
Las cantidades nominales describen la etiqueta; los resultados medidos figuran en cada informe. Un informe publicado no confirma el lote asignado a un pedido futuro.
Preguntas sobre el producto y la documentación
¿Cómo interpreto el tamaño y la cantidad?
La cantidad por vial y los viales por caja aparecen por separado. El precio corresponde a una caja. En mezclas, el tamaño puede ser combinado; consulte la etiqueta y el informe para cada componente.
¿Cómo encuentro el COA correspondiente?
Compare producto, SKU y número de lote. La página del lote muestra resultados, informe original y enlace de verificación. Consulte al soporte si su pedido no indica el lote asignado.
¿Un resultado de pureza significa que se aprobaron todas las pruebas?
No. Identidad, pureza, llenado y endotoxinas son mediciones distintas. Revise cada resultado y unidad. Un resultado ausente no equivale a aprobado, y un valor inferior a un límite no es cero.
Research Information
GLOW50 provides a defined 35:10:5 mg per-vial formulation of GHK-Cu, TB-500 and BPC-157. Relevant ingredient literature covers fibroblast matrix synthesis, preclinical tendon biology and analytical identification of material described as TB-500. These distinct evidence streams provide research context rather than proof of activity for the combined formulation.
GLOW50 (GHK-Cu + TB-500 + BPC-157) Research & Studies
Composition and presentation
Each vial contains GHK-Cu 35 mg, TB-500 10 mg and BPC-157 5 mg, totaling 50 mg of labeled components. Packaging is 10 vials per box. The mass listing describes formulation content rather than an experimental concentration or use regimen.
GHK-Cu research context
GHK-Cu is a copper-complexed tripeptide investigated for matrix-associated cellular responses. Primary studies examined collagen synthesis and glycosaminoglycan production in fibroblast cultures. These findings are appropriate background for laboratory studies, without demonstrating a cosmetic or clinical outcome for GLOW50.
BPC-157 research context
BPC-157 is a synthetic pentadecapeptide studied in rat tendon models and cultured tendon cells. Reported endpoints include tendon-cell growth and growth-hormone-receptor expression. Such preclinical findings should remain linked to the individual compound and experimental model.
Interpreting TB-500 references
Analytical research identified the N-acetylated thymosin beta-4 fragment Ac-LKKTETQ in one TB-500 preparation. This catalog name alone does not verify the sequence of the supplied ingredient. Match product-specific analytical identity to each paper before using fragment or full-length thymosin beta-4 findings as research background.
Distinction from BBG50 and evidence limits
GLOW50 contains 35 mg GHK-Cu and 5 mg BPC-157 per vial, compared with 50 mg and 10 mg in BBG50; both list 10 mg TB-500. GLOW50 therefore totals 50 mg, while BBG50 totals 70 mg. The cited ingredient studies do not establish equivalent responses, superior performance or synergy for either blend.
Frequently Asked Questions
What is in each GLOW50 vial?
GHK-Cu 35 mg, TB-500 10 mg and BPC-157 5 mg, totaling 50 mg. Each box contains 10 vials.
Is GLOW50 interchangeable with BBG50 in research?
They have different component amounts and should not be treated as identical formulations. Any comparison needs to account for the concentration and verified identity of each component.
Does the GLOW name establish a skin benefit?
No. It is a catalog name. The referenced fibroblast studies provide ingredient-level research context and do not establish a skin or cosmetic outcome for this blend.
What is the intended research scope?
Laboratory characterization and exploratory studies informed by the individual ingredients' literature. The product is for research only, not human or veterinary use.
Learn more
Read research overviews, COA verification guides, and reconstitution notes in our Knowledge Hub.